Error message

Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1445 of /home/patently/domains/xepc.eu/public_html/includes/bootstrap.inc).
Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1445 of /home/patently/domains/xepc.eu/public_html/includes/bootstrap.inc).
Deprecated function: Optional parameter $type declared before required parameter $nid is implicitly treated as a required parameter in include_once() (line 1445 of /home/patently/domains/xepc.eu/public_html/includes/bootstrap.inc).

G 0001/03 (Disclaimer/PPG) of 8.4.2004

European Case Law Identifier:

ECLI:EP:BA:2004:G000103.20040408

Date of decision:

08 April 2004

Case number:

G 0001/03

Referral:

Application number:

IPC class:

Language of proceedings:

EN

Distribution:

A

Download and more information:

Decision text in EN (PDF, 80Â KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in:	EN
Versions:	OJ \| Published

Title of application:

Heat processable metallic appearing coatings

Applicant name:

PPG Industries Ohio, Inc.

Opponent name:

SAINT-GOBAIN GLASS FRANCE

Board:

EBA

Headnote:

1. An amendment to a claim by the introduction of a disclaimer may not be refused under Article 123(2) EPC for the sole reason that neither the disclaimer nor the subject-matter excluded by it from the scope of the claim have a basis in the application as filed.
2. The following criteria are to be applied for assessing the allowability of a disclaimer which is not disclosed in the application as filed:
2.1 A disclaimer may be allowable in order to:
- restore novelty by delimiting a claim against state of the art under Article 54(3) and (4) EPC;
- restore novelty by delimiting a claim against an accidental anticipation under Article 54(2) EPC; an anticipation is accidental if it is so unrelated to and remote from the claimed invention that the person skilled in the art would never have taken it into consideration when making the invention; and
- disclaim subject-matter which, under Articles 52 to 57 EPC, is excluded from patentability for non-technical reasons.
2.2 A disclaimer should not remove more than is necessary either to restore novelty or to disclaim subject-matter excluded from patentability for non-technical reasons.
2.3 A disclaimer which is or becomes relevant for the assessment of inventive step or sufficiency of disclosure adds subject-matter contrary to Article 123(2) EPC.
2.4 A claim containing a disclaimer must meet the requirements of clarity and conciseness of Article 84 EPC.

Relevant legal provisions:

European Patent Convention 1973 Art 52
European Patent Convention 1973 Art 53
European Patent Convention 1973 Art 54(2)
European Patent Convention 1973 Art 54(3)
European Patent Convention 1973 Art 54(4)
European Patent Convention 1973 Art 56
European Patent Convention 1973 Art 57
European Patent Convention 1973 Art 60(2)
European Patent Convention 1973 Art 84
European Patent Convention 1973 Art 87(1)
European Patent Convention 1973 Art 112(1)
European Patent Convention 1973 Art 123(2)
European Patent Convention 1973 Art 123(3)
European Patent Convention 1973 Art 139(2)
European Patent Convention 1973 R 27(1)(b)
European Patent Convention 1973 R 29(1)

Keywords:

Allowability of disclaimers - delimitation against state of the art under Article 54(2) and (3)(4) - accidental anticipation - exclusion of subject-matter not eligible for patent protection
Drafting of disclaimers - requirements of clarity and conciseness

Catchwords:

-

Cited decisions:

G 0005/83
G 0001/93
G 0002/98
T 0013/84
T 0292/85
T 0313/86
T 0170/87
T 0301/87
T 0238/88
T 0939/92
T 0074/93
T 0608/96
T 0323/97
T 1071/97
T 0351/98
T 0451/99

Citing decisions:

G 0001/07
G 0002/10
G 0002/12
G 0002/13
G 0001/15
G 0001/16
G 0001/18
G 0003/19
T 0426/98
T 0740/98
T 0201/99
T 0268/99
T 0431/99
T 0507/99
T 0699/99
T 0717/99
T 1049/99
T 1050/99
T 1086/99
T 0062/00
T 0234/00
T 0285/00
T 0426/00
T 0500/00
T 0531/00
T 0548/00
T 0627/00
T 0725/00
T 0747/00
T 0810/00
T 0918/00
T 0968/00
T 1074/00
T 1102/00
T 1120/00
T 1139/00
T 0002/01
T 0010/01
T 0014/01
T 0084/01
T 0120/01
T 0134/01
T 0208/01
T 0236/01
T 0298/01
T 0454/01
T 0580/01
T 0584/01
T 0629/01
T 0639/01
T 0667/01
T 0739/01
T 0788/01
T 0814/01
T 0866/01
T 0931/01
T 0990/01
T 0999/01
T 1004/01
T 1076/01
T 1131/01
T 1146/01
T 1195/01
T 0041/02
T 0067/02
T 0161/02
T 0319/02
T 0327/02
T 0349/02
T 0438/02
T 0506/02
T 0703/02
T 0706/02
T 0817/02
T 0868/02
T 0970/02
T 1028/02
T 1170/02
T 1182/02
T 0175/03
T 0178/03
T 0213/03
T 0217/03
T 0285/03
T 0495/03
T 0566/03
T 0720/03
T 0724/03
T 0782/03
T 0910/03
T 0992/03
T 1035/03
T 1113/03
T 1223/03
T 1241/03
T 0133/04
T 0154/04
T 0210/04
T 0279/04
T 0437/04
T 0440/04
T 0543/04
T 0696/04
T 0792/04
T 0868/04
T 0933/04
T 1247/04
T 1326/04
T 1331/04
T 1345/04
T 0029/05
T 0035/05
T 0069/05
T 0083/05
T 0086/05
T 0176/05
T 0248/05
T 0342/05
T 0357/05
T 0380/05
T 0471/05
T 0540/05
T 0543/05
T 0544/05
T 0580/05
T 0582/05
T 0601/05
T 0602/05
T 0609/05
T 0708/05
T 0788/05
T 0795/05
T 1119/05
T 1120/05
T 1121/05
T 1141/05
T 1180/05
T 1213/05
T 1286/05
T 1337/05
T 1420/05
T 1470/05
T 1522/05
T 1559/05
T 0005/06
T 0033/06
T 0236/06
T 0286/06
T 0493/06
T 0544/06
T 0588/06
T 0876/06
T 0985/06
T 0998/06
T 1107/06
T 1194/06
T 1242/06
T 1268/06
T 1308/06
T 1455/06
T 1551/06
T 1847/06
T 1924/06
T 0008/07
T 0107/07
T 0146/07
T 0159/07
T 0382/07
T 0762/07
T 0777/07
T 0824/07
T 0919/07
T 1068/07
T 1099/07
T 1158/07
T 1212/07
T 1357/07
T 1695/07
T 1721/07
T 1771/07
T 2009/07
T 2020/07
T 0005/08
T 0115/08
T 0156/08
T 0323/08
T 0342/08
T 0386/08
T 0397/08
T 0626/08
T 0650/08
T 0680/08
T 0756/08
T 0761/08
T 1049/08
T 1079/08
T 1092/08
T 1144/08
T 1326/08
T 1509/08
T 1705/08
T 1870/08
T 1911/08
T 1925/08
T 2018/08
T 2036/08
T 2165/08
T 2321/08
T 0022/09
T 0076/09
T 0103/09
T 0108/09
T 0197/09
T 0258/09
T 0385/09
T 0477/09
T 0748/09
T 0913/09
T 0947/09
T 1036/09
T 1045/09
T 1176/09
T 1334/09
T 1336/09
T 1374/09
T 1393/09
T 1425/09
T 1447/09
T 1457/09
T 1487/09
T 1599/09
T 1659/09
T 1843/09
T 2102/09
T 2213/09
T 0122/10
T 0275/10
T 0289/10
T 0447/10
T 0657/10
T 0759/10
T 0912/10
T 0958/10
T 1070/10
T 1128/10
T 1319/10
T 1821/10
T 1836/10
T 2136/10
T 2184/10
T 2311/10
T 2464/10
T 0074/11
T 0270/11
T 0352/11
T 0484/11
T 0528/11
T 0595/11
T 0617/11
T 0625/11
T 0704/11
T 0754/11
T 0833/11
T 0862/11
T 1147/11
T 1171/11
T 1222/11
T 1226/11
T 1301/11
T 1823/11
T 1839/11
T 2130/11
T 2618/11
T 0136/12
T 0282/12
T 0313/12
T 0336/12
T 0351/12
T 0475/12
T 0562/12
T 0632/12
T 0760/12
T 0767/12
T 0992/12
T 1032/12
T 1270/12
T 1272/12
T 1297/12
T 1899/12
T 2001/12
T 2043/12
T 0217/13
T 0352/13
T 0389/13
T 0404/13
T 0557/13
T 0574/13
T 0730/13
T 0850/13
T 0852/13
T 0876/13
T 0895/13
T 1165/13
T 1271/13
T 1399/13
T 1441/13
T 1656/13
T 1678/13
T 1790/13
T 1808/13
T 2030/13
T 2502/13
T 0075/14
T 0099/14
T 0330/14
T 0437/14
T 0489/14
T 1086/14
T 1218/14
T 1224/14
T 1662/14
T 1845/14
T 1872/14
T 1934/14
T 2000/14
T 0944/15
T 1311/15
T 1326/15
T 1354/15
T 1525/15
T 1635/15
T 1984/15
T 2097/15
T 2099/15
T 2284/15
T 0161/16
T 0189/16
T 0283/16
T 0284/16
T 0600/16
T 0694/16
T 0712/16
T 0875/16
T 0941/16
T 1001/16
T 1099/16
T 1137/16
T 1260/16
T 1384/16
T 1400/16
T 1469/16
T 1532/16
T 1711/16
T 1921/16
T 2114/16
T 2184/16
T 2210/16
T 2350/16
T 2355/16
T 2635/16
T 0409/17
T 0853/17
T 0890/17
T 1077/17
T 1169/17
T 1533/17
T 1900/17
T 2381/17
T 2540/17
T 0311/18
T 0395/18
T 1255/18
T 1272/18
T 2275/18
T 2277/18
T 2537/18
T 1916/19
T 3077/19
T 2015/20

Source: http://www.epo.org/law-practice/case-law-appeals/recent/g030001ex1.html

Date retrieved: 17 May 2021

238 references found. Limiting display to 200 references.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

X A.52 EPC Patentable inventions

X A.53 EPC Exceptions to patentability

X A.54 EPC Novelty

X A.56 EPC Inventive step

X A.57 EPC Industrial application

X A.60 EPC Right to a European patent

X A.84 EPC Claims

X A.87 EPC Priority right

X A.112 EPC Decision or opinion of the Enlarged Board of Appeal

X A.123 EPC Amendments

X A.139 EPC Prior rights and rights arising on the same date

EPC Implementing Rules

X R.42 EPC Content of the description

EPO Guidelines - F The European Patent Application

X GL F III 5.1 Only variants of the invention are incapable of being performed

X GL F III 12 Sufficiency of disclosure and inventive step

X GL F IV 4.19 Negative limitations (e.g. disclaimers)

X GL F VI 2.2 The same invention

EPO Guidelines - G Patentability

X GL G II 5.4 Plant and animal varieties or essentially biological processes for the production of plants or animals

EPO Guidelines - H Amendments and Corrections

X GL H V 4.1 The subject-matter to be excluded is not disclosed in the application as originally filed (so-called undisclosed disclaimers)

Case Law Book: I Patentability

X CLR I A 1 Patent protection for technical inventions

X CLR I B 4.3.5.B Disclaimer

X CLR I C 4.10 Accidental disclosure

Case Law Book: II Conditions to be met by an Application

X CLR II C 3.2 Alleged effect not a feature of the claims

X CLR II C 5.2 Indication of at least 'one way'

X CLR II C 6.1 Repeatability

X CLR II C 7.2 Level of disclosure required for medical use – plausibility

X CLR II C 7.3 Level of disclosure required for antibodies

X CLR II D 3.1.2 ‍‍G 2/98 and the concept of disclosure – interpretation in the same way as for Art. 123(2) EPC

X CLR II D 3.1.6 Enabling disclosure in the priority document

X CLR II D 4.1 Identity of invention

X CLR II E 1.1 General principles

X CLR II E 1.7.1 Definition

X CLR II E 1.7.2 Standards for examining disclosed and undisclosed disclaimers

X CLR II E 1.7.2.A Principles established in G 1/03 and G 2/03 for undisclosed disclaimers

X CLR II E 1.7.2.B Principles established in G 2/10 for disclosed disclaimers

X CLR II E 1.7.2.C Explanations in G 1/16

X CLR II E 1.7.3.A Accidental anticipation

X CLR II E 1.7.3.B Drafting of disclaimers – disclaimer shall not remove more than is necessary

X CLR II E 1.7.3.D Drafting of disclaimers – delimitation against any potential prior art

X CLR II E 1.7.3.E Drafting of disclaimers – clarity

X CLR II E 1.7.3.F Undisclosed disclaimer must not be related to the teaching of the invention

X CLR II E 1.7.3.G Negative features

X CLR II E 1.7.5 Applicability of the decisions of the Enlarged Board to cases already pending

X CLR II E 1.15 "Comprises", "consists of", "consists essentially of", "contains"

X CLR II E 3.2 Attempts to resolve the conflict

Case Law Book: III Amendments

X CLR III A 5.1 Case law deviating from or overruling the practice

X CLR III H 1.2.3 Teleological interpretation

X CLR III N 2.4 Anonymously filed observations

Case Law of the Enlarged Board

X G 0005/83 (Second medical indication) of 5.12.1984

X G 0001/93 (Limiting feature) of 2.2.1994

X G 0002/98 (Requirement for claiming priority of the "same invention") of 31.5.2001

X G 0001/07 (Treatment by surgery/MEDI-PHYSICS) of 15.2.2010

X G 0002/10 (Disclaimer/SCRIPPS) of 30.8.2011

X G 0002/12 () of 25.3.2015

X G 0002/13 () of 25.3.2015

X G 0001/15 () of 29.11.2016

X G 0001/16 (Disclaimer III) of 18.12.2017

X G 0001/18 (Filing an appeal) of 18.7.2019

X G 0003/19 (Pepper (follow-up to ÂTomatoes IIÂ and ÂBroccoli IIÂ)) of 14.5.2020

General Case Law

X T 0013/84 (Reformulation of the problem) of 15.5.1986

X T 0292/85 (Polypeptide expression) of 27.1.1988

X T 0313/86 () of 12.1.1988

X T 0170/87 (Hot-gas cooler) of 5.7.1988

X T 0301/87 (Alpha-interferons) of 16.2.1989

X T 0238/88 (Crown ether) of 25.4.1991

X T 0939/92 (Triazoles) of 12.9.1995

X T 0074/93 (Contraceptive method) of 9.11.1994

X T 0608/96 (Butylenoxid-Addukte/BASF) of 11.7.2000

X T 0323/97 (Disclaimer/UNILEVER) of 17.9.2001

X T 1071/97 (Vaccines/CHIRON) of 17.8.2000

X T 0351/98 (HIV-I/CHIRON CORPORATION) of 15.1.2002

X T 0740/98 (Dioxazines/SUMITOMO) of 9.11.2004

X T 0201/99 (Granulation process/UNILEVER) of 10.9.2004

X T 0451/99 (Synthetic antigens/GENETIC SYSTEMS) of 14.3.2003

X T 0507/99 (Disclaimers/PPG) of 20.12.2002

X T 0717/99 () of 18.11.2004

X T 1049/99 (Composition cosmÃ©tique fitrante/L'OREAL) of 9.11.2004

X T 1050/99 (Carbonyl hydrolases/GENENCOR) of 25.1.2005

X T 1086/99 (Edible oil/fat compositions/KAO CORPORATION) of 10.11.2004

X T 0285/00 (Dissolution aid/UNILEVER) of 22.10.2004

X T 0426/00 () of 27.6.2003

X T 0500/00 () of 17.6.2004

X T 0725/00 () of 16.6.2004

X T 0747/00 (Refrigerant working fluids/HENKEL) of 1.3.2005

X T 1074/00 (Hematopoietic growth factors/GENETICS INSTITUTE) of 13.5.2004

X T 1102/00 (Mammalian membrane receptors/CNRS) of 1.6.2004

X T 0010/01 (AIDS polypeptides/GENENTECH) of 9.3.2005

X T 0014/01 (Reduced dye release/UNILEVER) of 3.11.2004

X T 0134/01 (Immunosuppressives/VERTEX) of 27.1.2005

X T 0298/01 (DÃ©rivÃ©s oxysulfurÃ©s et fluorÃ©s/RHODIA CHIMIE) of 7.10.2004

X T 0580/01 (Hydroxycarboxylic acids/VAN SCOTT) of 29.11.2005

X T 0584/01 (Topically applied formulations/STAFFORD-MILLER LTD) of 21.4.2005

X T 0639/01 (Thiazole compounds/SEARLE) of 9.2.2005

X T 0667/01 (Optical recording medium/SANYO) of 15.2.2006

X T 0739/01 (NSAID for dementia/UNIVERSITY OF BRITISH COLUMBIA) of 6.10.2005

X T 0788/01 () of 13.6.2003

X T 0866/01 (Euthanasia Compositions/MICHIGAN STATE UNIV.) of 11.5.2005

X T 1004/01 () of 1.9.2004

X T 1146/01 () of 2.9.2004

X T 1195/01 () of 16.12.2005

X T 0041/02 () of 19.1.2006

X T 0067/02 (Kosmetische Zubereitungen mit Flavonoiden/Beiersdorf) of 14.5.2004

X T 0161/02 (Transgenic Zea mays plants/SYNGENTA) of 13.9.2004

X T 0506/02 (Measles virus/IMPFINSTITUT) of 18.1.2005

X T 1170/02 () of 1.3.2006

X T 0175/03 () of 3.11.2005

X T 0178/03 (Copper pyrithione) of 11.4.2006

X T 0217/03 (Low foaming APG/AKZO NOBEL) of 2.3.2005

X T 0285/03 (Field emission device/MOTOROLA) of 10.5.2005

X T 0724/03 () of 19.10.2006

X T 0910/03 () of 7.7.2005

X T 0992/03 () of 4.11.2010

X T 1241/03 (Human growth hormone/GENENTECH) of 1.9.2005

X T 0154/04 (Estimating sales activity / DUNS LICENSING ASSOCIATES) of 15.11.2006

X T 0440/04 (Vitreous fibres I/ROCKWOOL) of 26.11.2008

X T 0696/04 () of 15.9.2005

X T 0868/04 (Antifreeze compositions/ASHLAND) of 10.5.2006

X T 0933/04 () of 6.12.2007

X T 0029/05 (PVA/BRISTOL-MYERS) of 13.3.2006

X T 0083/05 (Broccoli/PLANT BIOSCIENCE) of 22.5.2007

X T 0248/05 (Particulate direct label/INVERNESS) of 25.4.2006

X T 0380/05 (GnRH Antagonists/PRAECIS) of 13.4.2006

X T 0471/05 () of 6.2.2007

X T 0601/05 (Anti-TNF alpha human monoclonal antibodies/BAYER III) of 2.12.2009

X T 0708/05 () of 14.2.2007

X T 0788/05 () of 8.5.2007

X T 1119/05 () of 8.1.2008

X T 1120/05 (Separation/DELAVAL) of 21.2.2008

X T 1180/05 () of 2.8.2007

X T 1213/05 (Breast and ovarian cancer/UNIVERSITY OF UTAH) of 27.9.2007

X T 0005/06 (Folate complex/PURDUE RESEARCH FOUNDATION) of 23.1.2009

X T 0033/06 (Fuel oil composition/INFINEUM) of 18.9.2007

X T 0286/06 (Soft creped tissue paper/PROCTER & GAMBLE) of 9.11.2007

X T 0493/06 (Phagemid/KREBSFORSCHUNGSZENTRUM) of 18.9.2007

X T 0876/06 () of 8.5.2007

X T 0985/06 (AmphoacÃ©tates tensio-actifs/RHODIA) of 16.7.2008

X T 1107/06 (Botulinum toxins/ALLERGAN.) of 3.12.2008

X T 1194/06 (Arylalkylamine carbamates/LABOARATORIOS S.A.L.V.A.T.) of 6.8.2009

X T 1242/06 (Tomatoes II/STATE OF ISRAEL) of 31.5.2012

X T 0008/07 (Disclaimer too broad (see reasons 2)) of 7.5.2009

X T 0146/07 (Prenatal diagnosis/ISIS) of 13.12.2011

X T 0382/07 (Etheric oils/D & W TRADING) of 26.9.2008

X T 0762/07 (Estrogen receptor/ORGANON) of 24.2.2009

X T 0777/07 (Methanol synthesis/MITSUBISHI) of 25.2.2011

X T 0824/07 () of 5.10.2007

X T 0919/07 (Loratadine/ROLABO) of 13.1.2009

X T 1068/07 (Enzymatic DNA/SCRIPPS) of 25.6.2010

X T 1695/07 () of 28.9.2011

X T 1721/07 (CSF-1 Inhibitoren/HOFBAUER UND AHARINEJAD) of 29.3.2012

X T 0386/08 (Humanized antibodies to the amyloid beta peptide/WASHINGTON … of 22.11.2010

X T 0761/08 () of 18.11.2010

X T 1079/08 (Derivatives of venlafaxine/SEPRACOR) of 19.4.2010

X T 1870/08 () of 13.3.2012

X T 1911/08 (NMDA/NR2B Antagonists/MERCK SHARP & DOHME) of 31.1.2012

X T 2165/08 (Bi-cyclic nucleoside analogues/EXIQON) of 6.3.2013

X T 2321/08 () of 11.5.2009

X T 0022/09 (Fischer-Tropsch Catalysts/ Sasol) of 5.2.2016

X T 0108/09 (Fulvestrant for treating resistant breast cancer/ASTRA ZENECA AB) of 14.2.2013

X T 0385/09 () of 25.11.2010

X T 0477/09 () of 10.6.2011

X T 1045/09 () of 17.1.2014

X T 1336/09 () of 14.12.2011

X T 1457/09 (CTL epitopes of WT-1/GANYMED PHARMACEUTICALS) of 17.1.2014

X T 1487/09 () of 24.9.2013

X T 1843/09 () of 6.6.2012

X T 0122/10 () of 9.12.2011

X T 0447/10 (Composition de teinture / L'OREAL) of 14.11.2013

X T 0657/10 (Stearidonic plant delta desaturases/CALGENE) of 19.12.2013

X T 0759/10 () of 22.3.2012

X T 1128/10 (SELF ADAPTIVE CEMENT\SCHLUMBERGER PRAD) of 20.11.2014

X T 1319/10 (Microbicidal composition/ROHM & HAAS COMPANY) of 22.1.2013

X T 1836/10 (Gewinnung von embryonalen Stammzellen/WÃRFEL) of 9.4.2013

X T 2311/10 () of 24.9.2012

X T 0270/11 (Kosmetische Zubereitungen/BEIERSDORF) of 6.6.2013

X T 0484/11 (Internet telephony/BT) of 8.11.2013

X T 0595/11 (Underpayment of appeal fee/Lely Enterprises AG) of 27.5.2015

X T 0617/11 () of 27.3.2015

X T 0625/11 () of 19.1.2017

X T 0833/11 (Fluticasone furoate/GLAXO) of 8.4.2014

X T 0862/11 (Polyelektrolytkapselsystem /HENKEL) of 17.3.2015

X T 1222/11 () of 4.12.2012

X T 1823/11 () of 20.5.2015

X T 1839/11 () of 29.6.2012

X T 2130/11 () of 2.12.2014

X T 0282/12 (Coated tablets /JOHNSON & JOHNSON) of 9.11.2017

X T 0351/12 () of 30.5.2017

X T 0475/12 () of 11.11.2015

X T 0632/12 (LDPC code parity-check matrix/GOOGLE TECHNOLOGY HOLDINGS) of 7.6.2017

X T 0760/12 (HGF/Met modulation/GENENTECH) of 27.11.2017

X T 1032/12 (Human TSLP/IMMUNEX CORPORATION) of 30.7.2015

X T 1272/12 () of 11.12.2014

X T 1297/12 () of 11.10.2016

X T 2001/12 () of 29.1.2015

X T 0389/13 () of 19.9.2017

X T 0404/13 () of 28.7.2015

X T 0557/13 (Partial Priority / Infineum) of 17.7.2015

X T 0895/13 (Conjugates/NOVARTIS) of 21.5.2015

X T 1165/13 () of 26.4.2016

X T 1271/13 () of 26.1.2018

X T 1399/13 () of 11.7.2018

X T 1441/13 (Embryonic stem cells, disclaimer /ASTERIAS) of 9.9.2014